Jci_page_head_homepage_01 Jci_page_head_homepage_02
Masaya Kobayashi, Mi-Na Kweon, Hirotaka Kuwata, Robert D. Schreiber, Hiroshi Kiyono, Kiyoshi Takeda, Shizuo Akira
Published in Volume 111, Issue 9
J Clin Invest. 2003; 111(9):1297–1308 doi:10.1172/JCI17085
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

IBDs in TNF-α/Stat3 double-deficient mice. (ad) Histologic examination of the colons of (a) control, (b) TNF-α–deficient, (c) Stat3 mutant, and (d) TNF-α/Stat3 double-mutant mice at 16 weeks. H&E staining is shown. ×20. (e) The colitis score of TNF-α/Stat3 double-mutant mice at 16 weeks of age. TNF-α/Stat3 double-mutant mice developed severe chronic colitis, similar to Stat3 mutant mice. *P < 0.001 versus group of control mice. (f) Mice were intraperitoneally injected with thioglycollate, and 3 days later peritoneal macrophages were isolated. Macrophages were stimulated with 10 ng/ml LPS for 24 h. Concentrations of TNF-α, IL-6, and IL-12p40 in the culture supernatants were measured. *Not detected.